{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:27:29Z","timestamp":1790418449792,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,11]]},"DOI":"10.7759\/cureus.69170","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T11:43:28Z","timestamp":1726055008000},"source":"Crossref","is-referenced-by-count":3,"title":["Impact of COVID-19 on Antibiotic Stewardship, Antimicrobial Resistance, and Prescribing Habits at Two General Hospitals in Abu Dhabi: A Retrospective Analysis"],"prefix":"10.7759","author":[{"given":"Kanika","family":"Vats","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Oommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Tackling drug-resistant infections globally. final report and recommendations. (2016). Accessed: July 3, 2024: https:\/\/amr-review.org\/Publications.html."},{"key":"ref2","unstructured":"WHO report on surveillance of antibiotic consumption. 2016-2018 early implementation. (2018). Accessed: July 25, 2024: https:\/\/iris.who.int\/handle\/10665\/277359."},{"key":"ref3","unstructured":"Antimicrobial resistance, fueled by the COVID-19 pandemic. Policy brief November 2021. (2022). Accessed. July 3, 2024: https:\/\/iris.paho.org\/handle\/10665.2\/55864."},{"key":"ref4","unstructured":"CD59\/INF\/10 - Plan of action on antimicrobial resistance. final report. (2021). Accessed: July 3, 2024: https:\/\/www.paho.org\/en\/documents\/cd59inf10-plan-action-antimicrobial-resistance-final-report."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2021.362","article-title":"The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network","volume":"43","author":"Weiner-Lastinger LM","year":"2022","unstructured":"Weiner-Lastinger LM, Pattabiraman V, Konnor RY, et al.. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol. 2022, 43:12-25. 10.1017\/ice.2021.362","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2020.06.192","article-title":"Could the COVID-19 pandemic aggravate antimicrobial resistance?","volume":"48","author":"Rossato L","year":"2020","unstructured":"Rossato L, Negr\u00e3o FJ, Simionatto S. Could the COVID-19 pandemic aggravate antimicrobial resistance?. Am J Infect Control. 2020, 48:1129-30. 10.1016\/j.ajic.2020.06.192","journal-title":"Am J Infect Control"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.12.087","article-title":"Antibiotics and antimicrobial resistance in the COVID-19 era: perspective from resource-limited settings","volume":"104","author":"Lucien MA","year":"2021","unstructured":"Lucien MA, Canarie MF, Kilgore PE, et al.. Antibiotics and antimicrobial resistance in the COVID-19 era: perspective from resource-limited settings. Int J Infect Dis. 2021, 104:250-4. 10.1016\/j.ijid.2020.12.087","journal-title":"Int J Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/trab048","article-title":"Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance","volume":"115","author":"Rodr\u00edguez-Ba\u00f1o J","year":"2021","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Rossolini GM, Schultsz C, et al.. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance. Trans R Soc Trop Med Hyg. 2021, 115:1122-9. 10.1093\/trstmh\/trab048","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa773","article-title":"Coronavirus disease 2019 and antimicrobial resistance: parallel and interacting health emergencies","volume":"72","author":"Nieuwlaat R","year":"2021","unstructured":"Nieuwlaat R, Mbuagbaw L, Mertz D, et al.. Coronavirus disease 2019 and antimicrobial resistance: parallel and interacting health emergencies. Clin Infect Dis. 2021, 72:1657-9. 10.1093\/cid\/ciaa773","journal-title":"Clin Infect Dis"},{"key":"ref10","unstructured":"UAE announces first case of new coronavirus. (2020). Accessed. July 26, 2023: https:\/\/wam.ae\/en\/details\/1395302819532."},{"key":"ref11","unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19 - 11 March 2020. (2020). Accessed. July 26, 2023: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-...."},{"key":"ref12","unstructured":"UAE coronavirus (COVID-19) updates. (2023). Accessed. July 16, 2024: https:\/\/covid19.ncema.gov.ae\/en."},{"key":"ref13","unstructured":"Department of Health Abu Dhabi. Research and Innovation Center. (2023). Accessed. January 22, 2023: https:\/\/www.doh.gov.ae\/en\/research\/landing-page."},{"key":"ref14","unstructured":"Department of Health Abu Dhabi. Strategic priorities and objectives. (2024). Accessed. July 26, 2024: https:\/\/www.doh.gov.ae\/en\/about\/priorities."},{"key":"ref15","unstructured":"Classification of diseases, functioning, and disability. ICD-10-CM. (2024). Accessed. June 7, 2024: https:\/\/www.cdc.gov\/nchs\/icd\/icd-10-cm\/index.html."},{"key":"ref16","unstructured":"Department of Health. DOH guidelines for antimicrobial stewardship programs. (2017). Accessed. July 16, 2024: https:\/\/www.doh.gov.ae\/en\/resources\/guidelines."},{"key":"ref17","unstructured":"Standard for monitoring and reporting of antimicrobial resistance (AMR). (2024). Accessed. July 16, 2024: https:\/\/www.coursehero.com\/file\/232747611\/standard-for-monitoring-reporting-antimicrobial-resistance-AMRpdf\/."},{"key":"ref18","article-title":"Abu Dhabi Antimicrobial Resistance AMR Surveillance Report","author":"Al Marzooqi A","year":"2023","unstructured":"Al Marzooqi A, Al Kaabi S. Abu Dhabi Antimicrobial Resistance AMR Surveillance Report. Ali MA (ed): Abu Dhabi Public Health Centre, Abu Dhabi, UAE; 2023."},{"key":"ref19","unstructured":"CDC. Antimicrobial resistance threats in the United States, 2021-2022. (2022). Accessed. July 16, 2024: https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/update-2022.html."},{"key":"ref20","unstructured":"WHO reports widespread overuse of antibiotics in patients hospitalized with COVID-19. (2024). Accessed. July 16, 2024: https:\/\/www.who.int\/news\/item\/26-04-2024-who-reports-widespread-overuse-of-antibiotics-in-patients--hospitalized-with...."},{"key":"ref21","unstructured":"CDC. Implementation of antibiotic stewardship core elements at small and critical access hospitals. (2024). Accessed. July 26, 2023: https:\/\/www.cdc.gov\/antibiotic-use\/hcp\/core-elements\/small-and-critical-access-hospitals.html."},{"key":"ref22","unstructured":"Core elements of hospital antibiotic stewardship programs. (2024). Accessed. July 26, 2023: https:\/\/www.cdc.gov\/antibiotic-use\/hcp\/core-elements\/hospital.html."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit TH","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE Jr, et al.. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007, 44:159-77. 10.1086\/510393","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003543.pub4","article-title":"Interventions to improve antibiotic prescribing practices for hospital inpatients","volume":"2","author":"Davey P","year":"2017","unstructured":"Davey P, Marwick CA, Scott CL, et al.. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017, 2:CD003543. 10.1002\/14651858.CD003543.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay JP","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, et al.. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019, 200:e45-67. 10.1164\/rccm.201908-1581ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.259","article-title":"Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules","volume":"169","author":"McCabe C","year":"2009","unstructured":"McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med. 2009, 169:1525-31. 10.1001\/archinternmed.2009.259","journal-title":"Arch Intern Med"},{"key":"ref27","article-title":"Vital signs: improving antibiotic use among hospitalized patients","volume":"63","author":"Fridkin S","year":"2014","unstructured":"Fridkin S, Baggs J, Fagan R, et al.. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014, 63:194-200.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2023.02.021","article-title":"A parallel and silent emerging pandemic: antimicrobial resistance (AMR) amid COVID-19 pandemic","volume":"16","author":"Rehman S","year":"2023","unstructured":"Rehman S. A parallel and silent emerging pandemic: antimicrobial resistance (AMR) amid COVID-19 pandemic. J Infect Public Health. 2023, 16:611-7. 10.1016\/j.jiph.2023.02.021","journal-title":"J Infect Public Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/284013-impact-of-covid-19-on-antibiotic-stewardship-antimicrobial-resistance-and-prescribing-habits-at-two-general-hospitals-in-abu-dhabi-a-retrospective-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T11:43:37Z","timestamp":1726055017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/284013-impact-of-covid-19-on-antibiotic-stewardship-antimicrobial-resistance-and-prescribing-habits-at-two-general-hospitals-in-abu-dhabi-a-retrospective-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.69170","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,11]]}}}